Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001380915 | SCV001579119 | pathogenic | Li-Fraumeni syndrome | 2022-10-12 | criteria provided, single submitter | clinical testing | A gross deletion of the genomic region encompassing the full coding sequence of the TP53 gene has been identified. Loss-of-function variants in TP53 are known to be pathogenic (PMID: 20522432). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. A similar copy number variant has been observed in individual(s) with ovarian cancer, breast cancer and leiomyosarcoma (PMID: 23172776, 26681312). For these reasons, this variant has been classified as Pathogenic. |